From: The HCV Synthesis Project: Scope, methodology, and preliminary results
Geographical Location of Studies in HCV Synthesis Project | ||
---|---|---|
Country | Number of Reports | Percentage |
Argentina | 4 | 0.6% |
Australia | 56 | 8.9% |
Austria | 8 | 1.3% |
Bangladesh | 4 | 0.6% |
Belgium | 7 | 1.1% |
Bosnia and Herzegovina | 1 | 0.2% |
Brazil | 20 | 3.2% |
Bulgaria | 2 | 0.3% |
Canada | 22 | 3.5% |
China | 17 | 2.7% |
Croatia | 2 | 0.3% |
Czech Republic | 5 | 0.8% |
Denmark | 3 | 0.5% |
Egypt | 1 | 0.2% |
England | 20 | 3.2% |
Estonia | 1 | 0.2% |
Finland | 2 | 0.3% |
France | 22 | 3.5% |
Georgia | 3 | 0.5% |
Germany | 19 | 3.0% |
Greece | 9 | 1.4% |
Haiti | 1 | 0.2% |
Hong Kong | 2 | 0.3% |
Hungary | 1 | 0.2% |
Iceland | 3 | 0.5% |
India | 7 | 1.1% |
Iran | 3 | 0.5% |
Ireland | 13 | 2.1% |
Israel | 2 | 0.3% |
*Italy | 47 | 7.5% |
Japan | 4 | 0.6% |
Lebanon | 2 | 0.3% |
Malaysia | 4 | 0.6% |
Martinique | 1 | 0.2% |
Mexico | 1 | 0.2% |
Multiple | 3 | 0.5% |
Nepal | 4 | 0.6% |
New Zealand | 8 | 1.3% |
Norway | 4 | 0.6% |
Pakistan | 1 | 0.2% |
Philippines | 1 | 0.2% |
Poland | 3 | 0.5% |
Portugal | 1 | 0.2% |
Russia | 11 | 1.8% |
Saudi Arabia | 4 | 0.6% |
Scotland | 20 | 3.2% |
Slovenia | 1 | 0.2% |
*Spain | 46 | 7.3% |
Sweden | 12 | 1.9% |
Switzerland | 7 | 1.1% |
Syria | 1 | 0.2% |
Taiwan | 9 | 1.4% |
Thailand | 13 | 2.1% |
The Netherlands | 10 | 1.6% |
UK | 3 | 0.5% |
USA | 139 | 22.2% |
Uzbekistan | 3 | 0.5% |
Vietnam | 3 | 0.5% |
Wales | 1 | 0.2% |